Successful prolonged use of recombinant human insulin-like growth factor-1 in a child with cystic fibrosis

Mark E. Haupt, Ellen E. Kim, Adrienne L. Prestridge

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Growth failure is a common and complicated process in children with cystic fibrosis (CF). Growth hormone, which is becoming a more commonly used agent in such patients, has demonstrated beneficial effects aside from increased growth velocity. Recently, insulin-like growth factor-1 has gained significant attention in the understanding of growth failure in children with CF. We report the successful prolonged use of recombinant human insulin-like growth factor-1 in an adolescent boy with CF, who demonstrated significant clinical benefits from the therapy.

Original languageEnglish
Pages (from-to)1137-1141
Number of pages5
JournalPediatric Pulmonology
Volume46
Issue number11
DOIs
StatePublished - Nov 1 2011
Externally publishedYes

Keywords

  • cystic fibrosis
  • growth failure
  • growth hormone
  • insulin-like growth factor

Fingerprint Dive into the research topics of 'Successful prolonged use of recombinant human insulin-like growth factor-1 in a child with cystic fibrosis'. Together they form a unique fingerprint.

  • Cite this